全部股東
股東類型
- 機構投資者44.20%
- 公眾及其他36.32%
- 個人與內幕人士14.83%
- 上市公司3.22%
- 私人企業1.42%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
JPMorgan Chase & Co. | 8.95% | 3,041.72 萬 | 1.34% | +459.39 萬 | 21/07/2026 |
State Street Global Advisors, Inc. | 7.04% | 2,393.03 萬 | 2.79% | -941.80 萬 | |
Andreas KlugeChief Medical Advisor | 6.67% | 2,267.50 萬 | 0.02% | +0 | |
Christian BehrenbruchCo-Founder, MD, Group CEO & Executive Director | 6.41% | 2,179.69 萬 | <0.01% | +6.79 萬 | 26/05/2026 |
Challenger Limited | 4.98% | 1,690.73 萬 | 0.07% | -19.52 萬 | |
Citigroup Inc. | 3.35% | 1,139.14 萬 | 0.01% | +6.04 萬 | 30/06/2026 |
Grand Pharmaceutical Group Limited | 3.22% | 1,094.72 萬 | <0.01% | +0 | |
Vanguard Capital Management, LLC | 2.38% | 808.83 萬 | 0.26% | +88.88 萬 | 30/06/2026 |
Australian Super Pty Ltd | 2.26% | 768.79 萬 | <0.01% | +0 | 31/12/2025 |
Norges Bank Investment Management | 1.89% | 642.91 萬 | <0.01% | +0 | 31/12/2025 |
Vanguard Investments Australia Limited | 1.85% | 628.77 萬 | 0.07% | +24.21 萬 | 31/05/2026 |
BlackRock, Inc. | 1.77% | 600.94 萬 | 0.04% | -10.85 萬 | 31/03/2026 |
UV-Cap GmbH & Co KG | 1.44% | 487.83 萬 | 0.17% | -54.90 萬 | |
RBC Global Asset Management Inc. | 1.28% | 434.03 萬 | <0.01% | -1.93 萬 | 31/12/2025 |
Mark NelsonInterim Independent Non-Executive Chair | 1.07% | 362.88 萬 | <0.01% | +0 | 18/03/2026 |
Oncidium Foundation | 0.74% | 251.36 萬 | <0.01% | +0 | |
Vanguard Fiduciary Trust Company | 0.73% | 248.41 萬 | 0.08% | +29.12 萬 | 30/06/2026 |
Netwealth Investments Ltd. | 0.71% | 240.66 萬 | 0.11% | +39.57 萬 | |
Sanlam Investments Uk Limited | 0.58% | 195.95 萬 | <0.01% | +0 | 30/06/2025 |
BetaShares Capital Limited | 0.57% | 195.37 萬 | 0.02% | +7.83 萬 | 30/06/2026 |